To the Editor: In their study of guest authorship and ghostwriting in publications related to rofecoxib, Dr Ross and colleagues1 published a 3-page table of articles describing clinical trial results or scientific reviews discussed internally within Merck (or whose author's name had been mentioned in Merck e-mail messages) prior to publication that proposed an external, academically affiliated investigator as an author. Despite a disclaimer in the Methods section (“[I]dentification of these articles does not imply that each was guest authored or ghostwritten; we examined these articles because we believed their discussion within internal documents . . . suggested that Merck was aware of the manuscript prior to publication and perhaps had provided support for the project”), inclusion of a review article within that table may suggest to the reader that it was inspired, previewed, authored, or paid for by Merck. This was not the case for at least 2 articles in that table: a review2 that I coauthored and a review3 for which I was sole author.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.